tiprankstipranks
Advertisement
Advertisement

Evonik price target raised to EUR 20 from EUR 18 at Goldman Sachs

Goldman Sachs analyst Georgina Fraser raised the firm’s price target on Evonik (EVKIF) to EUR 20 from EUR 18 and keeps a Buy rating on the shares. The firm sees price increases in the company’s Advanced Technologies segment more than offsetting anticipated volume declines.

Meet Samuel – Your Personal Investing Prophet

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1